Insider Trading History of Mpm Bioventures V Llc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Mpm Bioventures V Llc since 2013. The trader's CIK number is 1482715. At the time of the last reporting, Mpm Bioventures V Llc was the 10% Owner of Rhythm Pharmaceuticals, Inc.. (stock ticker symbol RYTM). Also see all insider trading activities at Rhythm Pharmaceuticals, Inc..

Note that in the past MPM BIOVENTURES V LLC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Rhythm Pharmaceuticals, Inc. (RYTM) by Mpm Bioventures V Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 RYTM 100,000 $1,700,000 0 $0 0 $0

Yearly summary of insider trading at Aratana Therapeutics, Inc. (PETX) by Mpm Bioventures V Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 PETX 0 $0 600,000 $12,012,000 0 $0
2013 PETX 500,000 $3,000,000 0 $0 0 $0


Insider trading activities at 2 companies by Mpm Bioventures V Llc:

1. Rhythm Pharmaceuticals, Inc. (RYTM)

2. Aratana Therapeutics, Inc. (PETX)

Table 1. Insider trading of Rhythm Pharmaceuticals, Inc. (RYTM) by Mpm Bioventures V Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-10-10 RYTM Buy 100,000 17.00 1,700,000

Table 2. Insider trading of Aratana Therapeutics, Inc. (PETX) by Mpm Bioventures V Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-03-10 PETX Sale 600,000 20.02 12,012,000
2013-07-02 PETX Buy 500,000 6.00 3,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mpm Bioventures V Llc (10% Owner of Rhythm Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.